AAUM (Average Assets Under Management) of ₹97.09 Cr for Jul-Sep 2026 is the combined figure across Direct and Regular plans — sourced from AMFI India's quarterly disclosure. Equity Holdings above shows only the stock portion from the latest portfolio filing.
| Sector | Prev | Curr ▼ | Delta |
|---|---|---|---|
| Pharmaceuticals & Biotechnology | 62.6% | 62.7% | ▲ +0.1% |
| Healthcare Services | 29.1% | 30.1% | ▲ +1.0% |
| Chemicals & Petrochemicals | 5.2% | 5.7% | ▲ +0.5% |
| Sector | Prev | Curr ▼ | Delta |
|---|---|---|---|
| Pharmaceuticals & Biotechnology | 62.7% | 61.3% | ▼ -1.4% |
| Healthcare Services | 30.1% | 31.2% | ▲ +1.1% |
| Chemicals & Petrochemicals | 5.7% | 5.0% | ▼ -0.7% |
Comparing Aug 2026 → Sep 2026
| # | Stock | Sector | Weight (Sep 2026) |
|---|---|---|---|
| 1 | Nephrocare Health Services Ltd ₹3.03 Cr |
Healthcare Services | 3.05% |
| 2 | Piramal Pharma Limited ₹1.43 Cr |
Pharmaceuticals & Biotechnology | 1.43% |
| # | Stock | Sector | Aug 2026 | Sep 2026 | Change |
|---|---|---|---|---|---|
| 1 | Max Healthcare Institute Limited ₹2.98 Cr |
Healthcare Services | 2.55% | 2.99% | +0.44% |
| 2 | Syngene International Limited ₹1.37 Cr |
Healthcare Services | 0.97% | 1.38% | +0.41% |
| 3 | Mankind Pharma Limited ₹3.09 Cr |
Pharmaceuticals & Biotechnology | 2.89% | 3.11% | +0.22% |
| 4 | Zydus Lifesciences Limited ₹4.94 Cr |
Pharmaceuticals & Biotechnology | 4.79% | 4.97% | +0.18% |
| 5 | Metropolis Healthcare Limited ₹3.33 Cr |
Healthcare Services | 3.17% | 3.35% | +0.18% |
| 6 | Onesource Specialty Pharma Limited ₹2.28 Cr |
Pharmaceuticals & Biotechnology | 2.21% | 2.30% | +0.09% |
| 7 | Aurobindo Pharma Limited ₹5.19 Cr |
Pharmaceuticals & Biotechnology | 5.17% | 5.23% | +0.06% |
| 8 | Cohance Lifesciences Limited ₹2.93 Cr |
Pharmaceuticals & Biotechnology | 2.92% | 2.95% | +0.03% |
| # | Stock | Sector | Aug 2026 | Sep 2026 | Change |
|---|---|---|---|---|---|
| 1 | Artemis Medicare Services Limited ₹1.25 Cr |
Healthcare Services | 2.88% | 1.26% | -1.62% |
| 2 | IPCA Laboratories Limited ₹2.31 Cr |
Pharmaceuticals & Biotechnology | 3.18% | 2.33% | -0.85% |
| 3 | Gland Pharma Limited ₹3.18 Cr |
Pharmaceuticals & Biotechnology | 3.93% | 3.20% | -0.73% |
| 4 | Navin Fluorine International Limited ₹4.95 Cr |
Chemicals & Petrochemicals | 5.65% | 4.98% | -0.67% |
| 5 | Global Health Limited ₹2.58 Cr |
Healthcare Services | 3.19% | 2.59% | -0.60% |
| 6 | Sun Pharmaceutical Industries Limited ₹9.53 Cr |
Pharmaceuticals & Biotechnology | 10.09% | 9.59% | -0.50% |
| 7 | Apollo Hospitals Enterprise Limited ₹5.72 Cr |
Healthcare Services | 6.23% | 5.75% | -0.48% |
| 8 | Torrent Pharmaceuticals Limited ₹6.00 Cr |
Pharmaceuticals & Biotechnology | 6.45% | 6.04% | -0.41% |
| 9 | Glenmark Pharmaceuticals Limited ₹2.59 Cr |
Pharmaceuticals & Biotechnology | 2.88% | 2.61% | -0.27% |
| 10 | Neuland Laboratories Limited ₹6.10 Cr |
Pharmaceuticals & Biotechnology | 6.38% | 6.14% | -0.24% |
25 stocks — Sep 2026
| # | Stock | Sector | Cap | Weight & Value |
|---|---|---|---|---|
| 1 |
₹9.53 Cr |
Pharmaceuticals & Biotechnology |
9.59%
|
|
| 2 |
₹9.01 Cr |
Pharmaceuticals & Biotechnology |
9.07%
|
|
| 3 |
₹6.10 Cr |
Pharmaceuticals & Biotechnology |
6.14%
|
|
| 4 |
₹6.00 Cr |
Pharmaceuticals & Biotechnology |
6.04%
|
|
| 5 |
₹5.72 Cr |
Healthcare Services |
5.75%
|
|
| 6 |
₹5.19 Cr |
Pharmaceuticals & Biotechnology |
5.23%
|
|
| 7 |
₹4.95 Cr |
Chemicals & Petrochemicals |
4.98%
|
|
| 8 |
₹4.94 Cr |
Pharmaceuticals & Biotechnology |
4.97%
|
|
| 9 |
₹4.58 Cr |
Healthcare Services |
4.61%
|
|
| 10 |
₹3.74 Cr |
Healthcare Services |
3.77%
|
Disclaimer: Data sourced from individual AMC monthly portfolio disclosures, as mandated by SEBI/AMFI. While we strive for accuracy, errors in parsing or presentation may occasionally occur. This is not investment advice. Please consult a SEBI-registered investment adviser before making any investment decisions.
Found a discrepancy or have feedback? Contact Us — we read every message personally.